BSE: 532540 NSE: J B Chemicals & Pharmaceuticals ISIN: INE467B01029 SECTOR: IT Software Company Company’s Website: IPO Date & Price: July 29, 2004 | Rs.
J B Chemicals & Pharmaceuticals Overview:
| Stock Symbol in NSE | Stock Symbol in BSE | Current Price | Market Cap. (Cr) | P/E Ratio | Current EPS |
|---|
J B Chemicals & Pharmaceuticals Sector Performance and Peer Comparison with Sector Analysis:
Did You Know?
<Space for Feature Image>
- J B Chemicals & Pharmaceuticals is the
- Its Belong to Group.
Balance Sheets & Profit & Loss Account:
| Year | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
|---|
J B Chemicals & Pharmaceuticals Share Price Forecast Based on Current Growth +5/-5:
Share Price and EPS Forecast Based on Current Average Growth Rates:
| Next 5 Years (CG) | Next 10 Years (CG) | Next 20 Years (CG) |
|---|
Share Price and EPS Forecast Based on Current Average Growth Rates Plus 5%:
| Next 10 Years (CG+5%) | Next 20 Years (CG+5%) | Next 5 Years (CG+5%) |
|---|
Share Price and EPS Forecast Based on Current Average Growth Rates Minus 5%:
| Next 5 Years (CG-5%) | Next 10 Years (CG-5%) | Next 20 Years (CG-5%) |
|---|
J B Chemicals & Pharmaceuticals Quarterly Result, Date & Street Estimate:
| Share Name | Quarter Results | Year | Street Estimates | Profits | Growth |
|---|
Fundamental Analysis of J B Chemicals & Pharmaceuticals :
J B Chemicals & Pharmaceuticals Share Long Term Investment Price Target:
| Long Term Investment Tagets | Price | Qnt.Ratio |
|---|
J B Chemicals & Pharmaceuticals Fundamentals SWAT Analysis by AMT
Strengths, Weaknesses, Opportunities, and Threats of J B Chemicals & Pharmaceuticals
S
- Strengths Analysis will coming Soon.
W
- Weakness Analysis will coming Soon.
O
- Opportunity Analysis will coming Soon.
T
- Threats Analysis will coming Soon.
Where we can See J B Chemicals & Pharmaceuticals in Next 5 Year, 10 Year & 20 Year?
Technical Analysis of J B Chemicals & Pharmaceuticals :
J B Chemicals & Pharmaceuticals Share Weekly Swing Trading Price Target:
| Demand And Supply Zone | Support Levels | Support Price | Resistance Levels | Resistance Price |
|---|
J B Chemicals & Pharmaceuticals Share Today Intraday Price Target:
| IntradayTarget Today [Short Selling] | IntradayTarget Today [Long Buying] |
|---|
FAQ on J B Chemicals & Pharmaceuticals :
Yes, J B Chemicals & Pharmaceuticals is India Number-1 IT Software company, with lots business potential in next few year. Its Fundamentally strong Stock we recommend to buy at around 20-25 PE Ration price target. Anyway This company is quite famous for Good Dividends.
J B Chemicals & Pharmaceuticals is a Debt free company. Its can easily survived any down turn for 5-10 Quarter business growth.
Currently J B Chemicals & Pharmaceuticals is Trading at P/E Ratio which is
Both and working as a
Do to Covid-19 pandemic J B Chemicals & Pharmaceuticals Share drastically fall.
Its depend on when you and at what price you have buy this share, J B Chemicals & Pharmaceuticals at 20-25 P/E Ration is a excellent buy call for long Term Investment.
J B Chemicals & Pharmaceuticals ‘s Products/Projects:
| Products/Projects | Description/Valuation |
| A. | |
| B. | |
| C. |
IPO, Split, Bonus, Dividend Buyback History:
J B Chemicals & Pharmaceuticals First IPO was initiate on July 29, 2004. equity shares were put on sale during the IPO with a price band of Rs -Rs per equity share.
[ninja_tables id=”80424″
Company Profile:
| CEO Name | Nikhil Chopra |
| CFO Name | Vijay Bhatt |
| CEO Salary | N/A |
| Company Address | Diamond Harbour Rd, Ekbalpur, Khidirpur, Kolkata, West Bengal 700023 |
| Contact Number | 033 2455 0066 |
| Email Address | [email protected] |
Declaration: Investing in the Stock market is full of Risky. AllMoneyTips.COM doesn’t give any guarantee or warranted on its investment advice. Do your research before investing in the stock market. Our Forecast and buying selling levels of stocks is based on price action and demand and supply zone. There is no guarantee come with our prediction. Take it as advice only. We are not responsible for your losses on your investments.